YARNO WENDY L — SEC insider filings

SEC reporting owner CIK 1181186. 36 insider filings on record with FilingPulse; latest filed 2026-09-17.

Transaction summary — filings shown

Covers all 36 filings on record, filed 2020-11-19 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Tarsus Pharmaceuticals, Inc. (TARS)Director13——26
INOVIO PHARMACEUTICALS, INC. (INO)Director8——22
Global Blood Therapeutics, Inc. (GBT)Director3——16
IDEAYA Biosciences, Inc. (IDYA)Director6——6
MyoKardia, Inc. (MYOK)Director1——6
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)Director5——5

Insider filings — YARNO WENDY L

FiledFormIssuerReported transactionsSource
2026-09-174Tarsus Pharmaceuticals, Inc. (TARS)Option exercise (M): 302 · Option exercise (M): 302 (derivative) @ $0EDGAR
2026-06-294Tarsus Pharmaceuticals, Inc. (TARS)Grant/award (A): 3,837 (derivative) @ $0 · Grant/award (A): 2,417 (derivative) @ $0 · Grant/award (A): 1,209 (derivative) @ $0EDGAR
2026-06-184IDEAYA Biosciences, Inc. (IDYA)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2026-06-164Tarsus Pharmaceuticals, Inc. (TARS)Option exercise (M): 2,954 · Option exercise (M): 2,954 (derivative) @ $0EDGAR
2026-05-214INOVIO PHARMACEUTICALS, INC. (INO)Grant/award (A): 41,800 (derivative) @ $0 · Grant/award (A): 34,200 (derivative) @ $0EDGAR
2025-06-264IDEAYA Biosciences, Inc. (IDYA)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2025-06-174IOVANCE BIOTHERAPEUTICS, INC. (IOVA)Grant/award (A): 67,546 (derivative) @ $0EDGAR
2025-06-164Tarsus Pharmaceuticals, Inc. (TARS)Option exercise (M): 3,350 · Grant/award (A): 4,540 (derivative) @ $0 · Grant/award (A): 2,954 (derivative) @ $0 · Option exercise (M): 3,350 (derivative) @ $0EDGAR
2025-05-214INOVIO PHARMACEUTICALS, INC. (INO)Option exercise (M): 2,167 · Option exercise (M): 2,167 (derivative) @ $0EDGAR
2024-06-254Tarsus Pharmaceuticals, Inc. (TARS)Option exercise (M): 3,350 · Option exercise (M): 3,350 (derivative) @ $0EDGAR
2024-06-144Tarsus Pharmaceuticals, Inc. (TARS)Grant/award (A): 5,000 (derivative) @ $0 · Grant/award (A): 3,350 (derivative) @ $0EDGAR
2024-06-134IOVANCE BIOTHERAPEUTICS, INC. (IOVA)Grant/award (A): 49,303 (derivative) @ $0EDGAR
2024-05-314IDEAYA Biosciences, Inc. (IDYA)Grant/award (A): 16,200 (derivative) @ $0EDGAR
2024-05-224INOVIO PHARMACEUTICALS, INC. (INO)Grant/award (A): 2,917 (derivative) @ $0 · Grant/award (A): 2,167 (derivative) @ $0EDGAR
2024-05-164INOVIO PHARMACEUTICALS, INC. (INO)Option exercise (M): 2,166 · Option exercise (M): 2,166 (derivative) @ $0EDGAR
2024-03-054IOVANCE BIOTHERAPEUTICS, INC. (IOVA)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2023-12-054Tarsus Pharmaceuticals, Inc. (TARS)Option exercise (M): 5,000 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2023-06-264Tarsus Pharmaceuticals, Inc. (TARS)Grant/award (A): 5,000 (derivative) @ $0 · Grant/award (A): 3,350 (derivative) @ $0EDGAR
2023-06-214Tarsus Pharmaceuticals, Inc. (TARS)Option exercise (M): 2,000 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2023-06-094IDEAYA Biosciences, Inc. (IDYA)Grant/award (A): 16,200 (derivative) @ $0EDGAR
2023-06-084IOVANCE BIOTHERAPEUTICS, INC. (IOVA)Grant/award (A): 12,988 (derivative) @ $0EDGAR
2023-05-164INOVIO PHARMACEUTICALS, INC. (INO)Option exercise (M): 19,000 · Option exercise (M): 19,000 (derivative) @ $0 · Grant/award (A): 35,000 (derivative) @ $0 · Grant/award (A): 26,000 (derivative) @ $0EDGAR
2023-04-204IOVANCE BIOTHERAPEUTICS, INC. (IOVA)Grant/award (A): 74,823 (derivative) @ $0EDGAR
2022-12-064Tarsus Pharmaceuticals, Inc. (TARS)Grant/award (A): 5,000 (derivative) @ $0EDGAR
2022-10-064Global Blood Therapeutics, Inc. (GBT)Disposition to issuer (D): 11,437 · Disposition to issuer (D): 3,600 (derivative) · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 5,247 (derivative) · +2 moreEDGAR
2022-07-014Tarsus Pharmaceuticals, Inc. (TARS)Grant/award (A): 7,000 (derivative) @ $0 · Grant/award (A): 2,000 (derivative) @ $0EDGAR
2022-06-164Global Blood Therapeutics, Inc. (GBT)Option exercise (M): 3,600 · Option exercise (M): 3,600 (derivative) @ $0 · Grant/award (A): 5,600 (derivative) @ $0 · Grant/award (A): 3,600 (derivative) @ $0EDGAR
2022-06-104IDEAYA Biosciences, Inc. (IDYA)Grant/award (A): 11,000 (derivative) @ $0EDGAR
2022-05-174INOVIO PHARMACEUTICALS, INC. (INO)Option exercise (M): 18,000 · Option exercise (M): 18,000 (derivative) @ $0 · Grant/award (A): 19,000 (derivative) @ $0 · Grant/award (A): 28,000 (derivative) @ $0EDGAR
2021-06-214Global Blood Therapeutics, Inc. (GBT)Option exercise (M): 3,037 · Option exercise (M): 3,037 (derivative) @ $0 · Grant/award (A): 5,600 (derivative) @ $0 · Grant/award (A): 3,600 (derivative) @ $0EDGAR
2021-06-174Tarsus Pharmaceuticals, Inc. (TARS)Grant/award (A): 5,000 (derivative) @ $0EDGAR
2021-06-164IDEAYA Biosciences, Inc. (IDYA)Grant/award (A): 11,000 (derivative) @ $0EDGAR
2021-05-174INOVIO PHARMACEUTICALS, INC. (INO)Option exercise (M): 8,700 · Grant/award (A): 27,000 (derivative) @ $0 · Grant/award (A): 18,000 (derivative) @ $0 · Option exercise (M): 8,700 (derivative) @ $0EDGAR
2020-12-074INOVIO PHARMACEUTICALS, INC. (INO)Option exercise (M): 4,090 · Option exercise (M): 4,090 (derivative) @ $0EDGAR
2020-11-234Tarsus Pharmaceuticals, Inc. (TARS)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2020-11-194MyoKardia, Inc. (MYOK)Code (U): 5,508 · Disposition to issuer (D): 22,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 6,600 (derivative) · Disposition to issuer (D): 3,000 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1181186 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs